Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Science Translational Medicine
|
July 29, 2020
siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
Wei Tao, Arif Yurdagul, Na Kong, et al.
ACS Nano
|
February 28, 2017
Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy
Xiaoding Xu, Jun Wu, Yanlan Liu, et al.
Nature Reviews. Methods Primers
|
April 28, 2022
Nanodelivery of nucleic acids
Bárbara B Mendes, João Conniot, Aviram Avital, et al.
Nature Metabolism
|
September 6, 2024
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Santosh R Sukka, Patrick B Ampomah, Lancia N F Darville, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 20, 2018
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy
Xiaoding Xu, Jun Wu, Shuaishuai Liu, et al.
Science Translational Medicine
|
June 24, 2021
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models
Yao-Xin Lin, Yi Wang, Jianxun Ding, et al.
Nature Communications
|
February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
Yuling Xiao, Jiang Chen, Hui Zhou, et al.
Nature Biomedical Engineering
|
December 23, 2022
Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles
Sejin Son, Jutaek Nam, April S Kim, et al.
Nano Letters
|
June 2, 2020
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
Yujing Li, Jianxun Ding, Xiaoding Xu, et al.
Science Translational Medicine
|
December 20, 2019
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes <i>p53</i>-deficient cancers to mTOR inhibition
Na Kong, Wei Tao, Xiang Ling, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Science Translational Medicine
|
July 29, 2020
siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
Wei Tao, Arif Yurdagul, Na Kong, et al.
ACS Nano
|
February 28, 2017
Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy
Xiaoding Xu, Jun Wu, Yanlan Liu, et al.
Nature Reviews. Methods Primers
|
April 28, 2022
Nanodelivery of nucleic acids
Bárbara B Mendes, João Conniot, Aviram Avital, et al.
Nature Metabolism
|
September 6, 2024
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Santosh R Sukka, Patrick B Ampomah, Lancia N F Darville, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 20, 2018
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy
Xiaoding Xu, Jun Wu, Shuaishuai Liu, et al.
Science Translational Medicine
|
June 24, 2021
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models
Yao-Xin Lin, Yi Wang, Jianxun Ding, et al.
Nature Communications
|
February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
Yuling Xiao, Jiang Chen, Hui Zhou, et al.
Nature Biomedical Engineering
|
December 23, 2022
Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles
Sejin Son, Jutaek Nam, April S Kim, et al.
Nano Letters
|
June 2, 2020
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
Yujing Li, Jianxun Ding, Xiaoding Xu, et al.
Science Translational Medicine
|
December 20, 2019
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes <i>p53</i>-deficient cancers to mTOR inhibition
Na Kong, Wei Tao, Xiang Ling, et al.
Page
of 12